High Performance Detection of Alzheimer’s Disease Biomarkers Based on Localized Surface Plasmon Resonance
Authors:
- Tan Nhiem LyTLTan Nhiem Ly
- Sangkwon ParkSPSangkwon Park
- 1 November 2020
- journal article
- research article
- Published by Elsevier in Journal of Industrial and Engineering Chemistry
- Vol. 91, 182-190
Abstract
No abstract availableKeywords
Funding Information
- Dongguk University
This publication has 39 references indexed in Scilit:
- An MRI measure of degenerative and cerebrovascular pathology in Alzheimer diseaseNeurology, 2018
- High performance plasma amyloid-β biomarkers for Alzheimer’s diseaseNature, 2018
- Nano-biosensors to detect beta-amyloid for Alzheimer's disease managementBiosensors and Bioelectronics, 2016
- Modified screen printed electrode for development of a highly sensitive label-free impedimetric immunosensor to detect amyloid beta peptidesAnalytica Chimica Acta, 2015
- Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the BrainArchives of Neurology, 2009
- Amyloid Precursor Protein, Presenilins, and α-Synuclein: Molecular Pathogenesis and Pharmacological Applications in Alzheimer’s DiseasePharmacological Reviews, 2002
- White matter damage in Alzheimer's disease assessed in vivo using diffusion tensor magnetic resonance imagingJournal of Neurology, Neurosurgery & Psychiatry, 2002
- Plasma and Cerebrospinal Fluid Levels of Amyloid β Proteins 1-40 and 1-42 in Alzheimer DiseaseArchives of Neurology, 2000
- Detection in life of confirmed Alzheimer's disease using a simple measurement of medial temporal lobe atrophy by computed tomographyThe Lancet, 1992
- The Topographical and Neuroanatomical Distribution of Neurofibrillary Tangles and Neuritic Plaques in the Cerebral Cortex of Patients with Alzheimer's DiseaseCerebral Cortex, 1991